Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2024)
Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -284,080.00 |
| Dec 31, 2023 | -41,758.00 |
| Sep 30, 2023 | -7,077.00 |
| Jun 30, 2023 | 78,198.00 |
| Mar 31, 2023 | 763,634.00 |
| Dec 31, 2022 | -369,175.00 |
| Sep 30, 2022 | 64,459.00 |
| Jun 30, 2022 | -529,300.00 |
| Mar 31, 2022 | 6,241.00 |
| Dec 31, 2021 | 33,835.00 |
| Sep 30, 2021 | 178,118.00 |
| Jun 30, 2021 | -221,088.00 |
| Mar 31, 2021 | -39,000.00 |
| Dec 31, 2020 | 85,532.00 |
| Sep 30, 2020 | -46,164.00 |
| Jun 30, 2020 | -1,351.00 |
| Mar 31, 2020 | -2,138.00 |
| Dec 31, 2019 | 1,156.00 |
| Sep 30, 2019 | 21,011.00 |
| Jun 30, 2019 | -10,435.00 |